NEW YORK (GenomeWeb News) – Qlucore has signed a distribution agreement with Novo Newton Scientific that allows the latter to market Qlucore's Omics Explorer software to pharmaceutical and biotechnology companies in Ireland, Spain, Italy, and South Africa.

Qlucore President Carl-Johan Ivarsson said that the arrangement with Novo Newton will increase the firm's market presence.

Tom Nugent, Novo Newton's CFO, added, "The amount of genomic data is growing very quickly, and there is strong demand for high quality solutions such as Qlucore."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.